NeuroSense Therapeutics management prepares for investor engagement at the 5th Annual ROTH Healthcare Opportunities Conference scheduled for September 29, 2026.
NeuroSense announced participation in a healthcare conference, a routine corporate event with no expected material impact on the stock.
NeuroSense Therapeutics Ltd. announced that management will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026. Executives will conduct one-on-one meetings with investors to discuss the company's ongoing clinical developments and strategic outlook.
NeuroSense is participating to engage with the investment community through one-on-one meetings and to represent the company at the 5th Annual ROTH Healthcare Opportunities Conference.